Browsing by Subject Daclatasvir

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
2016Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patientsRestelli, Umberto; Alberti, Alfredo; Lazzarin, Adriano; Bonfanti, Marzia; Nappi, Carmela; Croce, Davide
2018Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in ItalyRestelli, Umberto; Alberti, Alfredo; Lazzarin, Adriano; Bonfanti, Marzia; Nappi, Carmela; Croce, Davide